Cargando…

Viral RNA Shedding and Transmission Potential of Asymptomatic and Pauci-symptomatic COVID-19 Patients

Detalles Bibliográficos
Autores principales:	Gupta, Ajay, Jain, Sonia, Gupta, Vipul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403227/ https://www.ncbi.nlm.nih.gov/pubmed/34466627 http://dx.doi.org/10.1093/ofid/ofab112

Ejemplares similares

Infectivity of asymptomatic versus symptomatic COVID-19
por: Sayampanathan, Andrew A, et al.
Publicado: (2021)

Exceptionally high COVID-19 viral load and very long duration of shedding in a young pauci-symptomatic child with autism resident in an Italian nursing home
por: Grossi, Enzo, et al.
Publicado: (2021)

Viral Ribonucleic Acid Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Coronavirus Disease 2019 Patients
por: Samaddar, Arghadip, et al.
Publicado: (2020)

A case of COVID-19 with long duration of viral shedding
por: Wang, Changtai, et al.
Publicado: (2021)

Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase
por: Sohn, Yujin, et al.
Publicado: (2020)

Asymptomatic COVID-19 in hospital visitors: The underestimated potential of viral shedding
por: Passarelli, Victor C., et al.
Publicado: (2021)

Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India
por: Shete, Anita M., et al.
Publicado: (2021)

Pauci-symptomatic disseminated tuberculosis revealed by an increase in the specific antigen of the prostate
por: Kadouri, Youssef, et al.
Publicado: (2020)

SARS-CoV-2 Detected on Environmental Fomites for Both Asymptomatic and Symptomatic Patients with COVID-19
por: Yang, Minghui, et al.
Publicado: (2021)

People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission
por: Accordini, Silvia, et al.
Publicado: (2023)

Isolated pauci-immune pulmonary capillaritis
por: Mehrotra, Ashok Kumar, et al.
Publicado: (2015)

Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
por: Bae, Seongman, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
por: Rodeles, Luz María, et al.
Publicado: (2021)

Viral RNA Load in Symptomatic and Asymptomatic COVID-19 Omicron Variant-Positive Patients
por: Wu, Qian, et al.
Publicado: (2022)

Response to Letter to the Editor—Viral Ribonucleic Acid Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Coronavirus Disease 2019 Patients
por: Samaddar, Arghadip, et al.
Publicado: (2021)

Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration
por: Noh, Ji Yun, et al.
Publicado: (2020)

Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
por: Chen, Yi, et al.
Publicado: (2021)

Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort study
por: Kelly, J Daniel, et al.
Publicado: (2022)

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea
por: Han, Mi Seon, et al.
Publicado: (2020)

Norovirus shedding among symptomatic and asymptomatic employees in outbreak settings in Shanghai, China
por: Wu, Qiang-song, et al.
Publicado: (2019)

Exome sequencing identifies novel dysferlin mutation in a family with pauci-symptomatic heterozygous carriers
por: Jalali-Sefid-Dashti, Mahjoubeh, et al.
Publicado: (2018)

A rare case of isolated pauci–immune pulmonary capillaritis
por: Gupta, Raghav, et al.
Publicado: (2014)

Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19
por: He, Xi, et al.
Publicado: (2020)

Asymptomatic monkeypox infection: a call for greater control of infection and transmission
por: Reda, Abdullah, et al.
Publicado: (2023)

Pre-symptomatic and asymptomatic transmission of COVID-19: Implications for control measures in Qatar
por: Tawe`ngi, Abdelaziz M, et al.
Publicado: (2021)

Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study
por: Tan, Jianbin, et al.
Publicado: (2022)

A severe-type COVID-19 case with prolonged virus shedding
por: Liu, Yijie, et al.
Publicado: (2020)

Liver test abnormalities in asymptomatic and mild COVID-19 patients and their association with viral shedding time
por: Yu, Si-Yi, et al.
Publicado: (2022)

Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?
por: Pedersen, Rune M., et al.
Publicado: (2021)

Persistent Viral Shedding after SARS-CoV-2 Infection in an Infant with Severe Combined Immunodeficiency
por: Hariharan, Sankar Vaikom, et al.
Publicado: (2021)

Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19
por: Tepekule, Burcu, et al.
Publicado: (2021)

ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers
por: Qi, Furong, et al.
Publicado: (2021)

Re: Seah et al.: Assessing viral shedding and infectivity of tears in Coronavirus disease 2019 (COVID-19) patients (Ophthalmology. 2020;127:977-979)
por: Min, Jinjin, et al.
Publicado: (2020)

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
por: Rothe, Camilla, et al.
Publicado: (2020)

Reply to: Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?
por: Guo, Meng, et al.
Publicado: (2021)

Transpulmonary Bubble Transit in Severe COVID-19: Pulmonary Vasodilatation or Angiogenesis?
por: Chiang, Kate Chander, et al.
Publicado: (2021)

Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2
por: Li, W., et al.
Publicado: (2020)

Bovine coronavirus in naturally and experimentally exposed calves; viral shedding and the potential for transmission
por: Oma, Veslemøy Sunniva, et al.
Publicado: (2016)

Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Epigenetics may characterize asymptomatic COVID-19 infection
por: Arnold, Cosby G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldhiufdsbjf3iml02ffdqcjbmn